Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China

Li-ming Lu; Jun He; Jing-chun Zeng; Mu-xi Liao; Chao Jia; Hai-hua Pan

doi:10.1007/s11655-016-2451-z

Your Location：

Home >

Browse articles >

Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China

Updated：2021-08-27

- Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China
- Chinese Journal of Integrative Medicine Vol. 23, Issue 1, Pages: 10-17(2017)
- Affiliations：
  
  1. Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou,China
  2. Department of Acupuncture, First Affiliated Hospital, Guangzhou University of Chinese Medicine,Guangzhou,China
  3. Department of Acupuncture, Guangzhou University of Chinese Medicine,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by National Natural Science Foundation for Distinguished Young Scholars of China (No. 81303069)
- DOI：10.1007/s11655-016-2451-z
  CLC：
- Published：2017，
  
  Published Online：21 March 2016，
Scan for full text
Lu, Lm., He, J., Zeng, Jc. et al. Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China., Chin. J. Integr. Med. 23, 10–17 (2017). https://doi.org/10.1007/s11655-016-2451-z

Li-ming Lu, Jun He, Jing-chun Zeng, et al. Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China. [J]. Chinese Journal of Integrative Medicine 23(1):10-17(2017)
Lu, Lm., He, J., Zeng, Jc. et al. Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China., Chin. J. Integr. Med. 23, 10–17 (2017). https://doi.org/10.1007/s11655-016-2451-z DOI：

Li-ming Lu, Jun He, Jing-chun Zeng, et al. Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China. [J]. Chinese Journal of Integrative Medicine 23(1):10-17(2017) DOI： 10.1007/s11655-016-2451-z.

摘要

To evaluate and compare the reports' qualities of acupuncture randomized controlled trials (RCTs) conducted in China before and after the implementation of two guidelines

i.e.

the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA). Proportions of studies that reported CONSORT and STRICTA items were compared for the years before and after implementation of these two guidelines. In addition

the total score of each item's reporting were calculated and reported differences during different date ranges were compared. For CONSORT items (maximum score 8)

there was evidence of a slight improvement in reporting between 1994–1995 and 1999–2000 combined (2.5±0.6) and 2004–2005 and 2009–2010 combined (3.0±0.9; difference 0.4

95% confidence interval

0.3 to 0.6

P<0.01). For STRICTA items (maximum score 17)

there was evidence that a slight improvement in reporting between 1994–1995 and 1999–2000 combined (8.6±2.1) and 2004–2005 and 2009–2010 combined (10.1±1.8; difference 1.5

95% confidence interval

1.1 to 1.9

P<0.01). Quality of reporting for RCTs of acupuncture treatment conducted in China have generally improved since the introduction of the STRICTA and CONSORT guidelines.

Abstract

To evaluate and compare the reports' qualities of acupuncture randomized controlled trials (RCTs) conducted in China before and after the implementation of two guidelines

i.e.

the total score of each item's reporting were calculated and reported differences during different date ranges were compared. For CONSORT items (maximum score 8)

there was evidence of a slight improvement in reporting between 1994–1995 and 1999–2000 combined (2.5±0.6) and 2004–2005 and 2009–2010 combined (3.0±0.9; difference 0.4

95% confidence interval

0.3 to 0.6

P<0.01). For STRICTA items (maximum score 17)

there was evidence that a slight improvement in reporting between 1994–1995 and 1999–2000 combined (8.6±2.1) and 2004–2005 and 2009–2010 combined (10.1±1.8; difference 1.5

95% confidence interval

1.1 to 1.9

P<0.01). Quality of reporting for RCTs of acupuncture treatment conducted in China have generally improved since the introduction of the STRICTA and CONSORT guidelines.

关键词

acupuncturequality of reportingrandomized controlled trialsConsolidated Standards of Reporting Trials (CONSORT) statementStandards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA)

Keywords

references

Smith C, Crowther CA, Grant SJ. Acupuncture for induction of labour. Cochrane Database Syst Rev 2004.

Wang Y, Liu ZS, Peng WN, Zhao J, Liu BY. Acupuncture for stress urinary incontinence in adults. Cochrane Database Syst Rev 2013;7.

Langevin HM, Churchill DL, Cipolla MJ. Mechanical signaling through connective tissue: a mechanism for the therapeutic effect of acupuncture. FASEB J 2001;15:2275–2282.

Ernst E, Pittler MH, Wider B, Boddy K. Acupuncture: its evidence-base is changing. Am J Chin Med 2007;35:21–25.

Lee A, Copas JB, Henmi M, Gin T, Chung RC. Publication bias affected the estimate of postoperative nausea in an acupoint stimulation systematic review. J Clin Epidemiol 2006;59:980–983.

Chen W, Yang GY, Liu B, Manheimer E, Liu JP. Manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials. PLoS One 2013;8:e73764.

Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159–166.

He J, Du L, Liu G, Fu J, He X, Yu J, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials 2011;12:122.

Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:834–840.

MacPherson H, Altman DG, Hammerschlag R, Li YP, Wu TX, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010;7:e1000261.

MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. STandards for Reporting Interventions in Controlled Trails of Acupuncture. Acupunct Med 2002;20:22–25.

MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med 2001;9:246–249.

Prady SL, Richmond SJ, Morton VM, MacPherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS One 2008;3:e1577.

Moher D, Jones A, Lepage L, Group C. Use of the CONSORT statement and quality of reports of randomized trials. JAMA 2001;285:1992–1995.

Zhang Y, Peng W, Clarke J, Liu Z. Acupuncture for uterine fibroids. Cochrane Database Syst Rev 2010;1.

Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 2002;23:380–388.

Mills EJ, Wu P, Gagnier J, Devereaux PJ. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 2005;26:480–487.

Mills E, Wu P, Gagnier J, Heels-Ansdell D, Montori VM. An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently. J Clin Epidemiol 2005;58:662–667.

Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982–989.

Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001;285:1992–1995.

Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006;185:263–267.

Lu L, Liao M, Zeng J, He J. Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA. Expert Rev Anticancer Ther 2013;13:489–498.

Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy. herbal medicines and acupuncture. Int J Epidemiol 2001;30:526–531.

Partsinevelou A, Zintzaras E. Quality of reporting of randomized controlled trials in polycystic ovary syndrome. Trials 2009;10:106.

Xiao L, Shang HC, Wang JY, Hu J, Xiong J. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on mild cognitive impairment. PLoS One 2011;6:e16922.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Acupuncture for Patients with Chronic Spontaneous Urticaria: A Randomized, Sham-Controlled Pilot Trial

Related Author

No data

Related Institution

Center of Integrated Chinese Medicine, La Pitié Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris VI University (Pierre and Marie Curie University)

Department of Gynecology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine

Harvard Medical School

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Experimental Research Center, China Academy of Chinese Medical Sciences

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰